Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Castaldo

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Pharmacology & Physiology|May 26, 2010
Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patientsMaria A Sardo, Giuseppe Mandraffino, Stefania Riggio, et al.
Current Medical Research and Opinion|June 23, 2005
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patientsMaria Adriana Sardo, Salvatore Campo, Michele Bonaiuto, et al.
Clinical Chemistry|September 15, 2004
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individualsSalvatore Campo, Maria A Sardo, Alessandra Bitto, et al.
Clinical Biochemistry|April 17, 2004
The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patientsSalvatore Campo, Maria A Sardo, Giuseppe Trimarchi, et al.
Oncotarget|November 16, 2017
The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologiesLucia Buccarello, Alessandra Sclip, Matteo Sacchi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2018
Can Dietary and Physical Activity Modifications Reduce Breast Density in Postmenopausal Women? The DAMA Study, a Randomized Intervention Trial in ItalyGiovanna Masala, Melania Assedi, Francesco Sera, et al.
Mutation Research|May 19, 2005
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean populationSalvatore Campo, Adriana M Sardo, Giuseppe M Campo, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 4, 2002
Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjectsMaria A Sardo, Maria Castaldo, Maurizio Cinquegrani, et al.
Aging Clinical and Experimental Research|April 24, 2008
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenariansSalvatore Campo, Maria Adriana Sardo, Giuseppe Trimarchi, et al.
Tumori|October 10, 2014
The DAMA trial: a diet and physical activity intervention trial to reduce mammographic breast density in postmenopausal women in Tuscany, Italy. Study protocol and baseline characteristicsGiovanna Masala, Melania Assedi, Saverio Caini, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Pharmacology & Physiology|May 26, 2010
Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patientsMaria A Sardo, Giuseppe Mandraffino, Stefania Riggio, et al.
Current Medical Research and Opinion|June 23, 2005
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patientsMaria Adriana Sardo, Salvatore Campo, Michele Bonaiuto, et al.
Clinical Chemistry|September 15, 2004
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individualsSalvatore Campo, Maria A Sardo, Alessandra Bitto, et al.
Clinical Biochemistry|April 17, 2004
The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patientsSalvatore Campo, Maria A Sardo, Giuseppe Trimarchi, et al.
Oncotarget|November 16, 2017
The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologiesLucia Buccarello, Alessandra Sclip, Matteo Sacchi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2018
Can Dietary and Physical Activity Modifications Reduce Breast Density in Postmenopausal Women? The DAMA Study, a Randomized Intervention Trial in ItalyGiovanna Masala, Melania Assedi, Francesco Sera, et al.
Mutation Research|May 19, 2005
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean populationSalvatore Campo, Adriana M Sardo, Giuseppe M Campo, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 4, 2002
Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjectsMaria A Sardo, Maria Castaldo, Maurizio Cinquegrani, et al.
Aging Clinical and Experimental Research|April 24, 2008
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenariansSalvatore Campo, Maria Adriana Sardo, Giuseppe Trimarchi, et al.
Tumori|October 10, 2014
The DAMA trial: a diet and physical activity intervention trial to reduce mammographic breast density in postmenopausal women in Tuscany, Italy. Study protocol and baseline characteristicsGiovanna Masala, Melania Assedi, Saverio Caini, et al.
Pageof 3